
Annovis Bio, Inc. (ANVS)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
- Previous Close
1.0200 - Open
1.0200 - Bid 1.1100 x 110000
- Ask 1.1500 x 340000
- Day's Range
1.0100 - 1.1700 - 52 Week Range
0.9300 - 5.5000 - Volume
1,481,660 - Avg. Volume
902,764 - Market Cap (intraday)
48.227M - Beta (5Y Monthly) 1.23
- PE Ratio (TTM)
-- - EPS (TTM)
-1.7500 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
10.50 - Zacks Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
48.23M
-
Enterprise Value
29.50M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (current)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
16.34
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-142.36%
-
Return on Equity (ttm)
-703.68%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-49.52M
-
Diluted EPS (ttm)
-1.7500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
18.73M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-23.79M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.



